Skip to main content

Table 3 UGT1A1 polymorphisms and clinical variables of multivariate analysis for non-CR risk in AML

From: Influence of UGT1A1 polymorphisms on the outcome of acute myeloid leukemia patients treated with cytarabine-base regimens

Variables in the model

Non-CR risk after two courses of induction

Non-CR risk after the first course of induction

OR (95% CI)

P value

OR (95% CI)

P value

UGT1A1 *28/− or *6/−

0.547 (0.375–0.797)

0.002

0.622 (0.446–0.868)

0.005

Risk stratification groups

 

2.5 × 10−6

 

0.021

 Low vs intermediate

0.457 (0.269–0.776)

0.004

0.678 (0.455–1.011)

0.056

 High vs intermediate

2.045 (1.331–3.140)

0.001

1.365 (0.880–2.116)

0.164

WBC count, × 109/l

1.004 (1.001–1.007)

0.008

1.005 (1.001–1.008)

0.011

Age, years

1.014 (1.001–1.028)

0.036

1.005 (0.993–1.017)

0.448

  1. WBC white blood cell